According to a recent study, guselkumab is efficacious in patients with moderate-to-severe psoriasis and a history of cancer.
Lutikizumab effective in HS patients, new study shows
According to a recent study, lutikizumab 300 mg was shown to be more effective than placebo in hidradenitis suppurativa (HS) patients.
Study shows apremilast effective for moderate-to-severe plaque PsO in pediatric patients
According to a recent study, apremilast is effective for the treatment moderate-to-severe plaque psoriasis short-term in pediatric patients.
Blood monocyte count in PsO patients may predict early response to secukinumab
According to a recent study, plaque psoriasis patients with lower blood monocyte counts at baseline achieved early response and better outcomes when treated with secukinumab.
Skin microbiota may predict AD in infants
According to a recent study, biomarkers in the skin microbiota, antimicrobial peptides, and natural moisturizing factors may predict atopic dermatitis (AD) in infants.
Study shows liquid synthetic detergents best suited for AD patients
According to a recent study, liquid synthetic detergents are better suited for maintaining healthy skin barrier function in patients with atopic dermatitis (AD) than soaps.
Study shows most effective AD treatments may have greater risk of adverse events
According to a recent study, the most effective atopic dermatitis (AD) treatments may also have the greatest risk of adverse events.
Study suggests multidisciplinary approach best for difficult-to-control AD in youth
According to a recent study, a multidisciplinary approach using dermatologists, allergists and family members is most effective for treating difficult-to-control atopic dermatitis (AD) in children and adolescents.
Guselkumab shows significant scalp psoriasis clearance in skin of colour patients
According to a recent study, guselkumab has shown significant improvements in skin clearance, scalp itch, and patient-reported health-related quality of life in skin of colour patients with moderate-to-severe scalp psoriasis.
Study suggests multilevel changes may be needed to reduce impact of acne in trans patients
According to a recent study, multilevel changes may be needed to reduce the impact of acne-related stigma and barriers to acne treatment in transgender and gender-diverse individuals.
HealthMinute.TV 